Attached files

file filename
10-Q - FORM 10-Q - CardioGenics Holdings Inc.v315318_10q.htm
XML - IDEA: XBRL DOCUMENT - CardioGenics Holdings Inc.R9.htm
EX-31.1 - EXHIBIT 31.1 - CardioGenics Holdings Inc.v315318_ex31-1.htm
EX-31.2 - EXHIBIT 31.2 - CardioGenics Holdings Inc.v315318_ex31-2.htm
EX-32.1 - EXHIBIT 32.1 - CardioGenics Holdings Inc.v315318_ex32-1.htm
EXCEL - IDEA: XBRL DOCUMENT - CardioGenics Holdings Inc.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - CardioGenics Holdings Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - CardioGenics Holdings Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - CardioGenics Holdings Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - CardioGenics Holdings Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - CardioGenics Holdings Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - CardioGenics Holdings Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - CardioGenics Holdings Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - CardioGenics Holdings Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - CardioGenics Holdings Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - CardioGenics Holdings Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - CardioGenics Holdings Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - CardioGenics Holdings Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - CardioGenics Holdings Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - CardioGenics Holdings Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - CardioGenics Holdings Inc.R11.htm
v2.4.0.6
Net Loss per Share
6 Months Ended
Apr. 30, 2012
Net Loss per Share
9. Net Loss per Share

 

The following table sets forth the computation of weighted-average shares outstanding for calculating basic and diluted earnings per share (EPS):

 

    Three Months Ended 
April 30,
    Six Months Ended
April 30,
 
    2012     2011     2012     2011  
                         
Weighted-average shares - basic     55,626,166       54,036,505       55,626,166       53,746,365  
Effect of dilutive securities                        
Weighted-average shares - diluted     55,626,166       54,036,505       55,626,166       53,746,365  

 

 

Basic EPS and diluted EPS for the three and six months ended April 30, 2012 and 2011 have been computed by dividing the net loss available to common stockholders for each respective period by the weighted average shares outstanding during that period. All outstanding options, warrants and shares to be issued upon the exercise of the outstanding options and warrants representing 9,834,969 and 4,131,974 incremental shares respectively have been excluded from the six months ended April 30, 2012 and 2011 computation of diluted EPS as they are antidilutive given the net losses generated.